Survival outcomes associated with antidepressant use in glioblastoma: a cohort study - Top-Institutions - MDSpire

Survival outcomes associated with antidepressant use in glioblastoma: a cohort study

  • By

  • Yifei Sun

  • Mohammad Hamo

  • Travis Atchley

  • James M. Markert

  • Burt Nabors

  • Dagoberto Estevez-Ordonez

  • October 27, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Neurosurgery
    • Psychiatry
    • Cancer Epidemiology

  • #2

    Dana-Farber Cancer Institute / Brigham and Women's Hospital / Harvard Medical School
    Dana-Farber Cancer Institute / Brigham and Women's Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neuro-oncology
    • Psychiatry
    • Neurosurgery
    • Cancer Biology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Psychiatry
    • Neurosurgery
    • Translational Research

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neuro-oncology
    • Psychiatry
    • Neurosurgery
    • Cancer Epidemiology

Original Source(s)

Survival outcomes associated with antidepressant use in glioblastoma: a cohort study

  • by Yifei Sun, Mohammad Hamo, Travis Atchley, James M. Markert, Burt Nabors, Dagoberto Estevez-Ordonez

  • October 27, 2025

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer